Landsittel Michael 4
4 · Blueprint Medicines Corp · Filed May 17, 2024
Insider Transaction Report
Form 4
Landsittel Michael
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2024-05-15$106.56/sh−1,364$145,348→ 71,617 total - Sale
Common Stock
2024-05-15$107.17/sh−2,486$266,425→ 72,981 total
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on December 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.94 to $107.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (3) in this form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.23 to $106.86 per share.